Given the emerging medicinal potential of this molecule, we studied its role in host innate defense and have demonstrated that therapeutic suppression of SIRT1 might be accomplished with limited effects on the host myeloid cell response to bacterial infections. The gene discussed is SIRT1; the disease is bacterial infectious disease.